Allegra Battistoni


Titolo Pubblicato in Anno
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication JOURNAL OF CLINICAL MEDICINE 2024
Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies CURRENT HEART FAILURE REPORTS 2023
What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season? EUROPEAN HEART JOURNAL SUPPLEMENTS 2023
Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
SARS-CoV-2 Related Myocarditis. What We Know So Far JOURNAL OF CLINICAL MEDICINE 2023
Low Perception of Obesity as a Pathological Condition Among Italian Cardiologists HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2023
Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know REVIEWS IN CARDIOVASCULAR MEDICINE 2023
A contemporary update on cancer and takotsubo syndrome FRONTIERS IN CARDIOVASCULAR MEDICINE 2023
New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies MEDICAL SCIENCES 2022
Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination JOURNAL OF CARDIOVASCULAR MEDICINE 2022
Flu Vaccination as a Key Prevention Recommendation for Patients at High Cardiovascular Risk: The Next Season's Scenario HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2022
Diastolic Blood Pressure Levels and Cardiovascular Risk in Elderly Women: The Need for a Personalized Approach AMERICAN JOURNAL OF HYPERTENSION 2022
Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents? JOURNAL OF CARDIOVASCULAR MEDICINE 2022
Exploring the influence of takotsubo syndrome on oncologic patients' mortality FRONTIERS IN CARDIOVASCULAR MEDICINE 2022
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice INTERNATIONAL JOURNAL OF CARDIOLOGY 2022
Clinical characteristics and outcomes of patients with COVID-19 infection: the results of the SARS-RAS Study of the Italian Society of Hypertension HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2021
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2021
Sacubitril/Valsartan as a therapeutic tool across the range of Heart Failure phenotypes and ejection fraction spectrum FRONTIERS IN PHYSIOLOGY 2021
Repurposing cardio-metabolic drugs to fight Covid19 HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2021


  • LS1_5
  • LS1_9
  • LS1_13

Interessi di ricerca

Rischio cardiovascolare; ipertensione e danno d'organo; sistemi meuro-ormonali; cardio-oncologia.


arterial hypertension
neurohormonal inhibitors
cardiovascular prevention
anthracycline cardiotoxicity

Gruppi di ricerca

Gruppi di ricerca - Responsabile

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma